MX9203543A - Medicamento. - Google Patents

Medicamento.

Info

Publication number
MX9203543A
MX9203543A MX9203543A MX9203543A MX9203543A MX 9203543 A MX9203543 A MX 9203543A MX 9203543 A MX9203543 A MX 9203543A MX 9203543 A MX9203543 A MX 9203543A MX 9203543 A MX9203543 A MX 9203543A
Authority
MX
Mexico
Prior art keywords
hydrogen
4alkyl
medicine
medicament
chem
Prior art date
Application number
MX9203543A
Other languages
English (en)
Spanish (es)
Inventor
David Andrew Arlwydd Owen
Original Assignee
Smith Kline
French Lab Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10617727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203543(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline, French Lab Limited filed Critical Smith Kline
Publication of MX9203543A publication Critical patent/MX9203543A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX9203543A 1987-05-21 1992-06-26 Medicamento. MX9203543A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712073A GB8712073D0 (en) 1987-05-21 1987-05-21 Medicament
EP88304555A EP0299602B1 (en) 1987-05-21 1988-05-19 Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease

Publications (1)

Publication Number Publication Date
MX9203543A true MX9203543A (es) 1992-07-01

Family

ID=10617727

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203543A MX9203543A (es) 1987-05-21 1992-06-26 Medicamento.

Country Status (21)

Country Link
US (2) US4824860A (enExample)
EP (1) EP0299602B1 (enExample)
JP (1) JPH062672B2 (enExample)
AT (1) ATE83659T1 (enExample)
AU (1) AU599792B2 (enExample)
CA (1) CA1305421C (enExample)
DE (1) DE3876877T2 (enExample)
DK (1) DK169609B1 (enExample)
ES (1) ES2052717T3 (enExample)
GB (1) GB8712073D0 (enExample)
GR (1) GR3007251T3 (enExample)
HK (1) HK1000913A1 (enExample)
HU (1) HU201871B (enExample)
IE (1) IE63511B1 (enExample)
LU (1) LU90098I2 (enExample)
MX (1) MX9203543A (enExample)
NL (1) NL970006I2 (enExample)
NZ (1) NZ224709A (enExample)
PH (1) PH23867A (enExample)
PT (1) PT87542B (enExample)
ZA (1) ZA883602B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
GB9511366D0 (en) * 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9612752D0 (en) * 1996-06-19 1996-08-21 Smithkline Beecham Plc Novel treatment
ATE218548T1 (de) * 1996-08-27 2002-06-15 American Home Prod 4-aminoethoxy-indolon-derivate
ZA992670B (en) * 1998-04-13 2000-10-12 American Home Prod 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.
US6176242B1 (en) 1999-04-30 2001-01-23 Medtronic Inc Method of treating manic depression by brain infusion
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
JP4630665B2 (ja) * 2002-09-13 2011-02-09 モタック・ニューロサイエンス・リミテッド ２，３−ベンゾジアゼピンによる基底核関連運動障害の治療
CA2499200A1 (en) * 2002-09-17 2004-04-01 Motac Neuroscience Limited Use of compounds in the treatment of dyskinesia
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
WO2005051488A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Combination of dopamine agonists and monoamine reuptake inhibitors
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20090325911A1 (en) * 2005-10-21 2009-12-31 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of Androgens for the Treatment of Parkinson's Disease
KR101446813B1 (ko) * 2006-04-06 2014-10-01 뉴파쎄 인크. 도파민 연관된 상태의 치료를 위한 이식체
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (en) * 2008-09-01 2010-03-04 Lupin Limited Novel controlled release compositions of ropinirole
CA2738414C (en) 2008-09-29 2014-05-27 Wockhardt Research Centre Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
JP5820469B2 (ja) 2010-04-30 2015-11-24 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダンの経皮組成物
EP2688561B1 (en) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
EP2776020B1 (en) 2011-11-09 2019-09-11 Teikoku Seiyaku Co., Ltd. Methods for the treatment of skin neoplasms
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
US20150313891A1 (en) * 2014-05-02 2015-11-05 Abbvie Inc. Neuronal nicotinic agonists and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones

Also Published As

Publication number Publication date
NL970006I2 (nl) 1997-10-01
US4824860A (en) 1989-04-25
NL970006I1 (nl) 1997-04-01
DE3876877T2 (de) 1993-04-29
IE63511B1 (en) 1995-05-03
JPS63303966A (ja) 1988-12-12
DK169609B1 (da) 1994-12-27
JPH062672B2 (ja) 1994-01-12
IE881469L (en) 1988-11-21
CA1305421C (en) 1992-07-21
AU1644588A (en) 1988-11-24
NZ224709A (en) 1997-02-24
AU599792B2 (en) 1990-07-26
LU90098I2 (fr) 1997-09-25
HK1000913A1 (en) 1998-05-08
PT87542A (pt) 1989-05-31
DK275488D0 (da) 1988-05-19
GR3007251T3 (enExample) 1993-07-30
EP0299602B1 (en) 1992-12-23
US4912126A (en) 1990-03-27
EP0299602A2 (en) 1989-01-18
DE3876877D1 (de) 1993-02-04
ZA883602B (en) 1989-04-26
HUT47217A (en) 1989-02-28
PH23867A (en) 1989-11-23
GB8712073D0 (en) 1987-06-24
EP0299602A3 (en) 1990-06-06
HU201871B (en) 1991-01-28
DK275488A (da) 1988-11-22
ES2052717T3 (es) 1994-07-16
PT87542B (pt) 1992-09-30
ATE83659T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
AU599792B2 (en) Anti-parkinsonian indolone derivatives
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
MY101207A (en) Treatment of diseases caused by retroviruses
FI862011A0 (fi) Terapeutiska nukleosider.
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
DK1137762T3 (da) Behandling af Pompes sygdom
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
SE8500996D0 (sv) Method of treatment
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DK148288A (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
FR2617478B1 (fr) Nouveaux derives d'aryl-heteroaryl cetones, leur procede de preparation ainsi que leur application a titre de medicament
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
EP0202986A3 (en) Use of "naftidrofuryl" in the treatment of neuropathies